Bertie
search
auto_awesomeActioninventory_2Consultant review
Action 5 · Task 248 · Group 12

Establish Quantitative Success Metrics and Escalation Triggers

The founder defines unambiguous, objective metrics for evaluating technical readiness, IP protection status, and commercial traction at each phase. Simultaneously, they establish specific risk triggers—such as TTO negotiation stalls, patent rejections, or grant milestone failures—that mandate immediate strategic pivots or project pauses.

Objective

Defining objective criteria removes emotional bias and academic sentimentality from the spinout decision-making process. This provides the parent task with robust go or no-go governance, ensuring capital and effort are protected or reallocated efficiently.

What's expected from the founder

A structured governance framework document listing clear quantitative success metrics for technology readiness advancement, IP defensibility, and commercial interest, alongside predefined stop or pivot risk triggers.

psychologyBertie consultant stress-test

Five questions an expert would ask when reviewing your output

Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.

  1. 1

    What precise quantitative result during the grant validation phase would force you to abort the spinout attempt?

  2. 2

    How will you objectively measure whether a TTO negotiation has stalled beyond acceptable commercial limits?

  3. 3

    Why have you chosen these specific technical readiness thresholds as proxies for commercial investor readiness?

  4. 4

    What explicit risk trigger dictates an immediate escalation to institutional or independent expert mediation?

  5. 5

    How do your success criteria balance academic publishing targets against commercial trade secret preservation?